If You Will be in Melbourne for Ausbiotech 2024, the Accelagen Team Would Like to Meet with You
The Accelagen team will be in Melbourne for Ausbiotech once again this year and we want to see you there! Accelagen has proudly been a member of AusBiotech for many years. Their organization influences decisions associated with setting policy and supporting the growth of the local life sciences industry. Participation in the AusBiotech National Conference […]
Accelagen Offers Assurance and Convenience by Using Proven CDISC Standards with the Cutting-edge ePRO System
Accelagen proudly employs this system, as we are devoted to providing the best experience available. Using the ePRO platform, Accelagen provide patients with a unique link via their email, which leads to a very secure portal where site staff and patients can simply log in and report their outcomes within a private, secure environment. Additional […]
Accelagen Biggest Takeaway from Bio International in 2024: Interest in the Australian Advantage
Accelagen’s Time at Bio in San Diego: The Many Ongoing Conversations About the Australian Advantage The Accelagen team has just returned home earlier this month from another wonderful time attending the Bio International Conference – this time in sunny San Diego, California. We had the chance to meet with so many friends and colleagues, and […]
Accelagen will be on-hand in San Diego next week for Bio 2024
Accelagen will be on-hand in San Diego next week for Bio 2024 BIO 2024 represents our 3rd attendance at the Bio International Conference, and the 2nd consecutive year after Boston last year. The opportunities that attending the BIO conferences has provided to us have been amazing. We’ve been able to meet and engage with clients, […]
The Value of Strategic Consultation in Regulatory Affairs from Accelagen
Avoiding the Pitfalls that Can Arise During the Regulatory Submissions Process At Accelagen, our Regulatory Affairs team are involved in many parts of the drug development process, including, the management of regulatory applications for companies who are seeking marketing approval in Australia, New Zealand, or other countries. This area is predominantly where Accelagen has its […]
Streamline Your Clinical Trial Processes with Full-Service CRO Expertise
Streamline Your Clinical Trial Processes with Full-Service CRO Expertise In the highly competitive world of biopharmaceutical development, engaging the expertise of a full-service contract research organization (CRO) like Accelagen can revolutionize the process of clinical trials. Accelagen streamlines operations, enhances efficiency, and drives cost savings without compromising quality by offering a comprehensive range of services […]
The Advantage of Team Australia: Speed, Accuracy, and Reduced Cost
The Advantage of Team Australia: Speed, Accuracy, and Reduced Cost In today’s highly competitive pharmaceutical and biotech industries, choosing the right partner is paramount to success. As geographical boundaries become increasingly less of an obstacle, Australian-based Contract Research Organizations (CROs) such as Accelagen offer many advantages that significantly enhance drug development. However, when meeting with […]
Accelagen Continues Strategic Expansion into the U.S. During JP Morgan 2024
An increasing number of people are discovering that collaborating with an offshore Contract Research Organization (CRO) offers a surprising number of advantages for pharmaceutical and biotechnology companies looking to streamline their drug development processes. Specifically, offshore partnerships can significantly impact the speed, cost-effectiveness, and overall success of clinical trials and research endeavors. Additionally, working with […]